FOXBusiness.com

The Week's Top 10 Videos On MarketWatch

MarketWatch — Sat, 07 Nov 2009 13:01:00 GMT

The Week's Top 10 Videos On MarketWatch

Stimulus for tech and telecom $3B, but jobs still guesswork

Patrick Thibodeau — Sat, 07 Nov 2009 01:45:30 GMT

The U.S. government has spent about $700 million on IT and telecommunications products and services under its economic stimulus program, part of a total of $3 billion that's in the spending pipeline, according to a private analysis of this data. But how many jobs have been created is not as clear.

Update fixes iPhone sync problem with Windows 7 for some

Nancy Gohring — Sat, 07 Nov 2009 00:57:52 GMT

Gigabyte Technology issued a BIOS update on Friday that fixes a problem for some Windows 7 users who have been unable to sync their iPhones.

Cisco undervalues Tandberg, investment firms say

Stephen Lawson — Sat, 07 Nov 2009 00:51:00 GMT

Two investment consulting companies laid out objections to Cisco's US$3 billion offer for Norwegian videoconferencing vendor Tandberg on Friday, saying in an open letter to Cisco and a press interview that the bid undervalues Tandberg.

U.S. Regulators Close Gateway Bank, Prosperan Bank

Sat, 07 Nov 2009 00:43:50 GMT

U.S. Regulators Close Gateway Bank, Prosperan Bank

Market Winners & Losers: International Game Technology, AIG

David O'Brien — Sat, 07 Nov 2009 00:40:57 GMT

The major indexes ended the week on a positive note after the release of unemployment figures. The Dow closed up 0.2%, the S&P gained 0.3% and the Nasdaq added 0.3%.

Report: Citigroup Creator Apologizes for Merger

Sat, 07 Nov 2009 00:10:05 GMT

The Chairman and CEO in charge during the creation of Citigroup, now says the formation of the banking behemoth was a mistake.

Stocks In Focus For Monday

MarketWatch — Sat, 07 Nov 2009 00:04:00 GMT

Stocks In Focus For Monday

Detroit's Home Federal Savings 117th Bank Failure

Sue Chang — Fri, 06 Nov 2009 23:22:00 GMT

Detroit's Home Federal Savings 117th Bank Failure

Ziopharm Stock Soars on Cancer Drug News

Fri, 06 Nov 2009 23:12:53 GMT

Ziopharm Oncology (ZIOP) offered encouraging data from its cancer drug Zymafos on Frdiay, announcing an increase in survival of 50% for patients that also underwent chemotherapy.